Literature DB >> 10516009

Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

A Rodriguez1, M Armstrong, D Dwyer, E Flemington.   

Abstract

Expression of the Epstein-Barr virus (EBV) latency-associated genes activates cell cycle progression and drives immortalization of the infected cell. In contrast, progression of the EBV replication program occurs most efficiently in growth-arrested cells. Previous studies showed that the EBV-encoded immediate-early transcription factor, Zta, can induce expression of the cyclin-dependent kinase inhibitors, p21 and p27, the tumor suppressor, p53, and cell growth arrest. Moreover, Zta-mediated induction of growth arrest occurs independently of its transcriptional transactivation function. Here we show that substitution of Zta's basic DNA binding domain with the analogous region of the Zta homologue, c-Fos, abrogates Zta's ability to induce growth arrest and to induce p21, p27, or p53 expression, suggesting that protein-protein interactions between this region of Zta and key cell cycle control proteins are involved in signaling cell cycle arrest. We also show that despite the crucial role for Zta's basic domain in eliciting cell growth arrest, its amino terminus is required for efficient induction of p27 and it modulates the level of p53 induction. Last, we provide evidence that Zta-mediated inductions of p21, p27, and p53 occur, at least in part, through distinct pathways. Therefore, Zta interacts with multiple growth arrest pathways, a property which may have evolved partly as a means to ensure that lytic replication occurs in a growth-arrested setting in multiple different tissues in various states of differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516009      PMCID: PMC112935     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes.

Authors:  I Pérez-Roger; D L Solomon; A Sewing; H Land
Journal:  Oncogene       Date:  1997-05-22       Impact factor: 9.867

2.  Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.

Authors:  P M Lieberman; J M Hardwick; S D Hayward
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

3.  Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

Authors:  J Countryman; H Jenson; R Seibl; H Wolf; G Miller
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

Authors:  E Grogan; H Jenson; J Countryman; L Heston; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

Review 7.  Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

Authors:  S H Speck; T Chatila; E Flemington
Journal:  Trends Microbiol       Date:  1997-10       Impact factor: 17.079

8.  Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.

Authors:  N D Perkins; L K Felzien; J C Betts; K Leung; D H Beach; G J Nabel
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

9.  A second site for Epstein-Barr virus shedding: the uterine cervix.

Authors:  J W Sixbey; S M Lemon; J S Pagano
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

10.  Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos.

Authors:  P J Farrell; D T Rowe; C M Rooney; T Kouzarides
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  29 in total

Review 1.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha.

Authors:  Frederick Y Wu; Qi-Qun Tang; Honglin Chen; Colette ApRhys; Christopher Farrell; Jianmeng Chen; Masahiro Fujimuro; M Daniel Lane; Gary S Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

4.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

5.  Reactivation of the Epstein-Barr virus from viral latency by an S-adenosylhomocysteine hydrolase/14-3-3 zeta/PLA2-dependent pathway.

Authors:  Diana Maas; Claudine Maret; Lars Schaade; Simone Scheithauer; Klaus Ritter; Michael Kleines
Journal:  Med Microbiol Immunol       Date:  2006-06-21       Impact factor: 3.402

6.  Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency.

Authors:  Celine Schelcher; Sarah Valencia; Henri-Jacques Delecluse; Matthew Hicks; Alison J Sinclair
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Authors:  Jian Huang; Gangling Liao; Honglin Chen; Frederick Y Wu; Lindsey Hutt-Fletcher; Gary S Hayward; S Diane Hayward
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases.

Authors:  A G Polson; L Huang; D M Lukac; J D Blethrow; D O Morgan; A L Burlingame; D Ganem
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Identification of herpesvirus proteins that contribute to G1/S arrest.

Authors:  Patrick Paladino; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

10.  Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest.

Authors:  Yoshihiro Izumiya; Su-Fang Lin; Thomas J Ellison; Alon M Levy; Greg L Mayeur; Chie Izumiya; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.